Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca: FDA changes motavizumab review date
AstraZeneca: FDA changes motavizumab review date
AstraZeneca: FDA changes motavizumab review date
Submitted by
admin
on June 25, 2010 - 10:14am
Source:
Marketwatch
News Tags:
FDA
AstraZeneca
motavizumab
RSV
monoclonal antibodies
Headline:
AstraZeneca: FDA changes motavizumab review date
Do Not Allow Advertisers to Use My Personal information
